AlbuRx (CSL Behring AG)
Welcome to the PulseAid listing for the AlbuRx drug offered from CSL Behring AG. This Human Serum Albumin [EPC],Increased Intravascular Volume [PE],Increased Oncotic Pressure [PE],Osmotic Activity [MoA],Serum Albumin [Chemical/Ingredient] pharmaceutical is classified as a PLASMA DERIVATIVE. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same PLASMA DERIVATIVE drug type category.
LABELER NAME / MANUFACTURER: | CSL Behring AG |
NON-PROPRIETARY NAME: | ALBUMIN (HUMAN) |
SUBSTANCE NAME: | ALBUMIN HUMAN |
TYPE: | PLASMA DERIVATIVE |
PHARMA CLASS: | Human Serum Albumin [EPC],Increased Intravascular Volume [PE],Increased Oncotic Pressure [PE],Osmotic Activity [MoA],Serum Albumin [Chemical/Ingredient] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | SOLUTION |
MARKETING CATEGORY NAME: | BLA |
START MARKETING DATE: | 2009-01-06 |
END MARKETING DATE: | 0000-00-00 |
AlbuRx PLASMA DERIVATIVE Details:
Item Description | AlbuRx from CSL Behring AG |
LABELER NAME: | CSL Behring AG |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 12.5(g/50mL) |
START MARKETING DATE: | 2009-01-06 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 44206-251_5cdacd60-e24e-4406-bbbf-05710a251c52 |
PRODUCT NDC: | 44206-251 |
APPLICATION NUMBER: | BLA102366 |
Other ALBUMIN HUMAN Pharmaceutical Manufacturers / Labelers: